US OptionsDetailed Quotes
ASAN241220C4000
- 20.50
- 0.000.00%
15min DelayClose Dec 20 16:00 ET
0.00High0.00Low
20.50Open20.50Pre Close0 Volume30 Open Interest4.00Strike Price0.00Turnover0.00%IV13.01%PremiumDec 20, 2024Expiry Date17.68Intrinsic Value100Multiplier-2DDays to Expiry2.82Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.19Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Asana Stock Discussion
Sign in to post a comment
Market seem weak today. Guess is due to tmr have powell speech.
Sold 1/3 for **ASAN** at 27.65.
Sold 1/2 for **PRCH** at BE. Stop loss for remaining 1/2 will remain at ytd open price.
SL raise to be for** RKLB**.
TQQQ
Sold 1/3 for **ASAN** at 27.65.
Sold 1/2 for **PRCH** at BE. Stop loss for remaining 1/2 will remain at ytd open price.
SL raise to be for** RKLB**.
TQQQ
+1
$Asana (ASAN.US)$ The next pltr???
1
ASAN
1mins
Day
Sizing 20% at 1mins ORB at 25.08 with 4.26% SL, Strong volume.
AFRM
day
hourly
Sizing 22% at 71.72, Stopped loss at 70.16. Lost 0.5% of capital. weak volume
PRCH
hourly
day
After cut lost on AFRM, sizing 20% at 5.54 with 4.19% SL at Open price. Nice hourly chart.
1mins
Day
Sizing 20% at 1mins ORB at 25.08 with 4.26% SL, Strong volume.
AFRM
day
hourly
Sizing 22% at 71.72, Stopped loss at 70.16. Lost 0.5% of capital. weak volume
PRCH
hourly
day
After cut lost on AFRM, sizing 20% at 5.54 with 4.19% SL at Open price. Nice hourly chart.
+3
$Asana (ASAN.US)$ Asana business model in my view is just a simple task application. Be careful being caught by those media trying to hyde up its stock price.
1
$Asana (ASAN.US)$ i bought a lot at 21
1
1
$Biodexa Pharmaceuticals (BDRX.US)$ $Kirkland's (KIRK.US)$ $DocuSign (DOCU.US)$ $Aprea Therapeutics (APRE.US)$ $HilleVax (HLVX.US)$ $Asana (ASAN.US)$ $Rubrik (RBRK.US)$ $Cardio Diagnostics (CDIO.US)$ $Gaxos.ai (GXAI.US)$ $Universe Pharmaceuticals (UPC.US)$ $Northann (NCL.US)$ $Primega Group (PGHL.US)$ $The Lion Electric (LEV.US)$ $Zhibao Technology (ZBAO.US)$
📊⚡️📊
📊⚡️📊
6
$Asana (ASAN.US)$ I like this company because:
1. its founder is the current ceo, highly dedicated
2. it has very clear and stable target customers
3. the product itself has good ratings from users
4. the net loss is gradually decreasing and it is expected to be cash flow positive in the next quarter
5. people don't like it
![]()
1. its founder is the current ceo, highly dedicated
2. it has very clear and stable target customers
3. the product itself has good ratings from users
4. the net loss is gradually decreasing and it is expected to be cash flow positive in the next quarter
5. people don't like it
1
$Asana (ASAN.US)$ Major shareholders controlled almost 65% of the shares. Else this stock would have fallen to below $10
No comment yet
Mr Brooks : You are a fucking genius